High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders

Treatment discontinuation is a major challenge in routine clinical settings. Despite poor adherence to antipsychotic medication, long acting injectable (LAI) formulations are an underutilized option in psychotic disorders. Recently, an earlier and broader use of LAIs has been emphasized. However, fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Auxilia, Anna Maria, Buoli, Massimiliano, Caldiroli, Alice, Carnevali, Greta Silvia, Tringali, Agnese, Nava, Roberto, Clerici, Massimo, Capuzzi, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953565/
https://www.ncbi.nlm.nih.gov/pubmed/36830850
http://dx.doi.org/10.3390/biomedicines11020314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953565/
https://www.ncbi.nlm.nih.gov/pubmed/36830850
http://dx.doi.org/10.3390/biomedicines11020314

Ejemplares similares